JP2003504324A5 - - Google Patents

Download PDF

Info

Publication number
JP2003504324A5
JP2003504324A5 JP2001508953A JP2001508953A JP2003504324A5 JP 2003504324 A5 JP2003504324 A5 JP 2003504324A5 JP 2001508953 A JP2001508953 A JP 2001508953A JP 2001508953 A JP2001508953 A JP 2001508953A JP 2003504324 A5 JP2003504324 A5 JP 2003504324A5
Authority
JP
Japan
Prior art keywords
coated granules
coated
group
agent
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001508953A
Other languages
English (en)
Japanese (ja)
Other versions
JP4749639B2 (ja
JP2003504324A (ja
Filing date
Publication date
Priority claimed from FR9909047A external-priority patent/FR2795962B1/fr
Application filed filed Critical
Publication of JP2003504324A publication Critical patent/JP2003504324A/ja
Publication of JP2003504324A5 publication Critical patent/JP2003504324A5/ja
Application granted granted Critical
Publication of JP4749639B2 publication Critical patent/JP4749639B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001508953A 1999-07-08 2000-06-30 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法 Expired - Lifetime JP4749639B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9909047A FR2795962B1 (fr) 1999-07-08 1999-07-08 Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
FR99/09047 1999-07-08
PCT/FR2000/001855 WO2001003672A1 (fr) 1999-07-08 2000-06-30 Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif

Publications (3)

Publication Number Publication Date
JP2003504324A JP2003504324A (ja) 2003-02-04
JP2003504324A5 true JP2003504324A5 (enExample) 2010-12-02
JP4749639B2 JP4749639B2 (ja) 2011-08-17

Family

ID=9548029

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001508953A Expired - Lifetime JP4749639B2 (ja) 1999-07-08 2000-06-30 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法

Country Status (31)

Country Link
US (1) US6660382B2 (enExample)
EP (1) EP1194125B1 (enExample)
JP (1) JP4749639B2 (enExample)
KR (1) KR100767928B1 (enExample)
CN (1) CN1220485C (enExample)
AT (1) ATE360412T1 (enExample)
AU (1) AU760006B2 (enExample)
BG (1) BG65615B1 (enExample)
BR (1) BR0012250A (enExample)
CA (1) CA2375600C (enExample)
CY (1) CY1107695T1 (enExample)
CZ (1) CZ300154B6 (enExample)
DE (1) DE60034565T2 (enExample)
DK (1) DK1194125T3 (enExample)
DZ (1) DZ3257A1 (enExample)
EA (1) EA003161B1 (enExample)
ES (1) ES2284507T3 (enExample)
FR (1) FR2795962B1 (enExample)
HK (1) HK1049119B (enExample)
HU (1) HU229568B1 (enExample)
IL (2) IL147212A0 (enExample)
MA (1) MA25426A1 (enExample)
MX (1) MXPA01013354A (enExample)
NO (1) NO331256B1 (enExample)
NZ (1) NZ516594A (enExample)
PL (1) PL201782B1 (enExample)
PT (1) PT1194125E (enExample)
SK (1) SK287322B6 (enExample)
TR (1) TR200200013T2 (enExample)
WO (1) WO2001003672A1 (enExample)
ZA (1) ZA200200344B (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
AU2001277230A1 (en) * 2000-08-01 2002-02-13 Inhale Therapeutic Systems, Inc. Apparatus and process to produce particles having a narrow size distribution andparticles made thereby
GB0018968D0 (en) * 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
DE60124895D1 (de) * 2001-07-26 2007-01-11 Ethypharm Sa Umgehüllte Allylamine oder Benzylamine enthaltende Granulate, Verfahren zur Herstellung und in der Mundhöhle dispergierbare Tabletten enthaltend die umgehüllten Granulate
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
FR2834212B1 (fr) * 2001-12-27 2004-07-09 Besins Int Belgique Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
CA2492789C (en) * 2002-07-17 2012-07-03 Eurand Pharmaceuticals Limited Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
BR0312795A (pt) * 2002-07-19 2005-05-10 Ranbaxy Lab Ltd Apresentação farmacêutica de sumatriptan, processo para sua preparação e método para tratar a enxaqueca
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
FR2850275B1 (fr) 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040151771A1 (en) 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
BRPI0409962A (pt) 2003-05-08 2006-04-25 Nektar Therapeutics Uk Ltd co-formulação particulada de uma substáncia ativa e um excipiente, composição farmacêutica ou nutricêutrica, produto farmacêutico ou nutricêutico, método para preparar uma co-formulação particulada de uma substáncia ativa e um excipiente, e, uso de uma substáncia ativa e um excipiente
AU2004247076A1 (en) * 2003-06-06 2004-12-23 Glaxo Group Limited Composition comprising triptans and NSAIDs
EP1656117A1 (en) * 2003-08-11 2006-05-17 Merck Frosst Canada Ltd. Flavored taste-masked pharmaceutical formulation made using a one-step coating process
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (en) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP5123517B2 (ja) * 2005-11-14 2013-01-23 帝人ファーマ株式会社 アンブロキソール口腔内速崩性錠剤
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
JP5405752B2 (ja) * 2007-01-31 2014-02-05 大日本住友製薬株式会社 被覆された薬物含有粒子および該粒子を含む固形製剤
DE102007019071A1 (de) * 2007-04-23 2008-10-30 Ratiopharm Gmbh Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
KR100895942B1 (ko) * 2007-05-08 2009-05-07 조선대학교산학협력단 생약 추출물을 함유하는 구강 내 속붕해성 제제 조성물 및그의 제조 방법
WO2008149192A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2009073216A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
WO2010018614A1 (ja) * 2008-08-11 2010-02-18 味の素株式会社 呈味性が改善された親水性アミノ酸含有製剤
FR2935084B1 (fr) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques Additif pour l'alimentation animale et son procede de preparation
KR101069118B1 (ko) 2008-10-22 2011-09-30 경상대학교산학협력단 장용해성 염화콜린의 제조방법 및 이의 방법에 따라 제조되는 염화콜린
CN101879141B (zh) * 2009-05-05 2013-07-17 烟台绿叶动物保健品有限公司 一种掩味替米考星胃溶颗粒制剂
WO2010150221A1 (en) 2009-06-25 2010-12-29 Wockhardt Research Centre Taste masked pharmaceutical compositions of pregabalin
EP2316433A1 (en) * 2009-10-22 2011-05-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of flurbiprofen
HUE057248T2 (hu) * 2009-10-26 2022-04-28 Merck Sharp & Dohme Integráz inhibitort tartalmazó szilárd gyógyszerészeti kompozíciók
AU2010315414B2 (en) * 2009-10-28 2015-07-09 Mcneil-Ppc, Inc. Fast dissolving/disintegrating coating compositions
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
TR200909613A1 (tr) * 2009-12-22 2011-07-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Pregabalinin farmasötik bileşimleri.
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
EP2591774B1 (en) 2010-07-09 2020-05-27 Teijin Pharma Limited Orally disintegrating tablet
JP4803686B2 (ja) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
MX350838B (es) 2011-02-11 2017-09-18 Grain Proc Corporation * Composicion de sal.
KR101481772B1 (ko) * 2012-06-19 2015-01-14 주식회사 아리바이오 추출물을 고농도로 함유하는 과립 또는 환의 제조방법
CN102908337B (zh) * 2012-10-12 2014-03-05 大连医诺生物有限公司 微囊化氨基酸组合物及其制备方法
US8993041B2 (en) 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
WO2015130760A1 (en) 2014-02-25 2015-09-03 Orbis Biosciences, Inc. Taste masking drug formulations
US10213437B2 (en) 2014-05-08 2019-02-26 Ctc Bio, Inc. Pharmaceutical preparation for masked taste oral administration, containing clomipramine
WO2015170939A1 (ko) * 2014-05-08 2015-11-12 주식회사 씨티씨바이오 클로미프라민 함유 맛 차폐된 구강 투여용 약학 제제
RU2718906C2 (ru) 2016-01-20 2020-04-15 Теравида, Инк. Способы и композиции для лечения гипергидроза
JP6919119B2 (ja) * 2017-01-23 2021-08-18 日新製薬株式会社 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
FR3078630B1 (fr) 2018-03-08 2021-05-14 Karim Ioualalen Mode de formulation sous forme de solide divise hydrophobe
JP2020105173A (ja) * 2018-12-27 2020-07-09 日本ケミファ株式会社 ２種以上の薬物を含有する口腔内崩壊錠及びその製造方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
JPS62126122A (ja) 1985-11-27 1987-06-08 Showa Shinyaku Kk 表面コ−テイングされたイブプロフエン顆粒の製法
SE457326B (sv) 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
JPH0780754B2 (ja) 1986-08-06 1995-08-30 エーザイ株式会社 多顆粒型持続性錠剤
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
US5358717A (en) * 1989-12-22 1994-10-25 Syntex (U.S.A.) Inc. Directly-compressible naproxen or naproxen sodium compositions
JP2845342B2 (ja) * 1990-04-28 1999-01-13 大正製薬株式会社 ビタミンｄ▲下３▼誘導体含有固形製剤組成物
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
TW271400B (enExample) * 1992-07-30 1996-03-01 Pfizer
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
AUPO637197A0 (en) 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
DK0941075T3 (da) * 1997-01-06 2003-07-14 Pfizer Smagsmaskerende farmaceutisk doseringsform med hurtig frigivelse
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
BR9813808A (pt) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida
FR2785539B1 (fr) 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
US6451345B1 (en) * 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration

Similar Documents

Publication Publication Date Title
JP2003504324A5 (enExample)
JP4749639B2 (ja) 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法
AU776662B2 (en) Coating of tablet cores
ES2347968T3 (es) Preparacion solida que se disgrega rapidamente.
KR100591488B1 (ko) 항궤양 활성 화합물을 포함하는 경구용 약제학적 제제의 제조방법
JP2009537478A5 (enExample)
PL193673B1 (pl) Bezpostaciowa sól amonowa eprosartanu,jej granulat i biologicznie ulepszony preparat oraz sposoby ich wytwarzania i zastosowanie
JP2001524131A (ja) 安定な経口医薬品剤形
JP2002523443A (ja) オメプラゾール製剤
RU2000131592A (ru) Фармацевтическая композиция, покрытая энтеросолюбильной оболочкой, и способ ее получения
JPH04230625A (ja) 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
JP2012509329A5 (enExample)
JP4234427B2 (ja) 活性成分をベースとする微小顆粒およびその製造方法
PL186386B1 (pl) Sposób wytwarzania granulatu zawierającego aktywny przy podawaniu drogą doustną antybiotyk beta-laktamowy oraz sposób wytwarzania szybko rozpadającejsię postaci dawkowania zawierającej aktywny przy podawaniu drogą doustną antybiotyk beta-laktamowy
CN101579324B (zh) 一种奥美拉唑肠溶速释片的制备方法
RS51271B (sr) Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
JPH10504295A (ja) 医薬処方
CN102058561A (zh) 头孢地尼胶囊及其制备方法
CN103735525A (zh) 一种达泊西汀片剂及制备方法
CA2462905A1 (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease
EP2600847A1 (en) Oral pharmaceutical formulations of esomeprazole in the form of mups (multi unit pellets system) tablets
KR101084659B1 (ko) 에스오메프라졸의 과립 및 그 장용성 과립의 제조방법
GB2135191A (en) Medicaments containing muzolimine
CN101277680A (zh) 苦味活性成分的口腔分散片剂
KR100693877B1 (ko) 경구 투여 후 반추위에서 보호되는 염화콜린 제조방법